Aspergillus fumigatus is associated with mycetoma and allergic bronchopulmonary aspergillosis, the major non-invasive forms of pulmonary aspergillosis." Precipitating antibody to A fumigatus may be detected in serum in both disorders.?5 Allergic bronchopulmonary aspergillosis, the most common cause of pulmonary eosinophilia, may cause irreversible fibrosis.' Diagnosis is made on clinical and radiological criteria and supported by the finding of immediate skin reactivity, circulating specific IgE antibody to A fumigatus, and precipitin lines on agar gel double diffusion in unconcentrated or concentrated serum.46 In these disorders precipitin results are useful and their interpretation straightforward. In routine practice, however, a precipitin test may be requested because of a suspicion of A fumigatus involvement (as in difficult asthma), a positive skinprick test response to A fumigatus, suspicious radiological appearances, or peripheral blood eosinophilia. It is in these circumstances that precipitin results with varying degrees of positivity occur, which prove difficult to interpret in the context of the supposed or eventual diagnosis.
The agar gel double diffusion method is the standard method for detecting Aspergillus precipitins, but it is a qualitative test of low sensitivity. Enzyme linked immunosorbent assay (ELISA) methods for detecting specific IgG antibodies to A fumigatus have greater sensitivity."5 Many comparisons have been made between ELISA and agar gel double diffusion tests, but these have usually been limited to small numbers of highly selected patients. None has compared the clinical value of the two methods in routine practice.
We undertook this study to determine the meaning of a positive result in the precipitin test, to compare the agar gel double diffusion and ELISA methods in a primary referral population, and to evaluate the ELISA as a routine method for detecting IgG antibody to A fumigatus.
Methods

PATIENTS
Precipitins to A fumigatus were detected in serum samples from 98 patients who attended a primary referral centre during seven years. The first positive serum precipitin sample was used in this study. On the basis of the precipitin results the following four groups were defined: group 1-patients with three or more precipitin lines in unconcentrated serum; group 2-patients with one or two precipitin lines in unconcentrated serum; group 3-patients with precipitins detectable only after threefold concentration of serum; group 4-patients with precipitins to only one or two of the four antigen extracts tested even after threefold concentration of serum and not to the same extract.
A group of 18 randomly selected precipitin negative patients attending the chest clinic served as controls for the ELISA data.
Case notes were reviewed to determine the diagnosis and collate results of clinic investigations. In particular, we recorded blood eosinophilia (>0 5 x 109/1); positive skinprick test responses to A fumigatus and other common allergens; A fumigatus specific IgE (radioallergosorbent test (RAST), Phadenzym Pharmacia), sputum production, positive cultures, or microscopic appearances characteristic of A fumigatus and lung function tests (either forced expiratory volume in one second (FEVy), forced vital capacity (FVC), or peak expiratory flow (PEF). Chest radiographs were reviewed and subjects allocated to clinical groups by DJS without knowledge of their precipitin grouping. Mycetoma was diagnosed from the characteristic radiological appearances, consisting of the presence of a radio-opaque mass in a lung cavity with an air crescent. Allergic bronchopulmonary aspergillosis was diagnosed in accordance with accepted criteria: chest radiographic abnormalities, immediate cutaneous reactivity to Aspergillus, increased total and specific IgE antibodies to Aspergillus, peripheral blood eosinophilia, asthma, and proximal bronchiectasis45 (though bronchography had not been performed on all patients). Bronchiectasis, not associated with allergic bronchopulmonary aspergillosis, was diagnosed from a history of chronic (over three years) purulent sputum production, bronchographs showing distal bronchiectasis, and an absence of immediate skin reactivity to A fumigatus. Asthma was defined on the basis of a history of reversible symptoms of wheeze, chest tightness, and dyspnoea with a documented 15% reversibility of airflow obstruction (FEV1 or PEF) in response to inhaled salbutamol (200 pg).
AGAR GEL DOUBLE DIFFUSION
Each serum sample was tested against four extracts of A fumigatus, two from Bencard, one from the Mycology Reference Laboratory, and one produced from a local strain. ods. The ELISA also separated the different precipitin groups, although it did not completely distinguish the mycetoma and allergic bronchopulmonary aspergillosis groups from the non-aspergillosis groups.
In this study 43 of the 51 patients with precipitins in unconcentrated serum had a mycetoma or asthma and 28 of the 32 with asthma had allergic bronchopulmonary aspergillosis. Of the eight patients with neither myectoma nor asthma in groups 1 and 2, four died soon after assessment and the development ofantibody to Afumigatus was probably a terminal event related to impaired lung clearance mechanisms. Of the remainder, one had cystic fibrosis, one was repeatedly precipitin positive, and a further patient, with a specific binding index of 100, had extrinsic allergic alveolitis, probably related to exposure to aspergillus while working in a stable.
The clinical relevance ofprecipitins detected only after threefold concentration of serum may be difficult to determine. In this study only a third of patients in group 3 had aspergillosis.
In patients with allergic bronchopulmonary aspergillosis such results have always been considered to be positive. The proportion of precipitin positive patients with allergic bronchopulmonary aspergillosis increased from 60% to 84% when precipitins in concentrated serum were considered to represent a positive result. 4 The group 3 patients with allergic bronchopulmonary aspergillosis had significantly greater amounts of specific IgG according to ELISA than did the precipitin negative controls, suggesting that their precipitin results are clinically relevant. Among the patients with allergic bronchopulmonary aspergillosis, those in group 3 had specific binding index values significantly below those in groups 1 and 2, though the separation of most of the seven patients in group 3 from the precipitin negative controls and the asthmatic patients with a negative skin test response to A fumigatus suggests that precipitin results in concentrated serum should be considered to be positive when other criteria of allergic bronchopulmonary aspergillosis are met. The ELISA suggests that care is needed in interpreting the group 4 
